Alliance Healthcare backs campaign to bring vital medicines to Ukraine

Alliance Healthcare UK aids in the camapign for support for the Medicines to Ukraine initiative, which aims to supply hospitals in the war-torn country with the vital medicines they need to treat casualties from the conflict.
Following the start of the devastating war in Ukraine, countries all over the world have tried to show their support and send aid for the people of Ukraine.
The Medicines to Ukraine Campaign is a cross-European campaign started by Employed Pharmacists in Europe (EPhEU). The campaign seeks to source medicines from donations and get them to the casualties in hospitals, overcoming challenges such as proper quality control and transport and distribution issues.
In the UK, the Medicines to Ukraine pharmacy appeal is led by The Healthcare Distribution Association (HDA),
Pharmacists' Defence Association (PDA), and National Pharmacy Association (NPA). The appeal asks pharmacy teams to advocate for the campaign and encourage customers and the general public to donate to support the charity’s work.
Alliance Healthcare UK, as one of the country’s largest pharmaceutical wholesalers, is a key supporter of the Medicine to Ukraine Campaign. Alliance Healthcare UK has brought attention to the campaign via their wide distribution network and extensive communication capabilities, including a UK-wide poster drop to pharmacies of 15,000 posters.
The campaign obtains specialist medicines that are needed by Ukrainian hospitals that are running on depleted or non-existent stores, but still desperately trying to treat the casualties of war.
In the UK, £220,000 has been raised so far through the appeal, with a total of £3 million raised across all of Europe so far.
Martin Sawer, Executive Director of HDA commented:
“Our member companies’ distribution networks ensure a comprehensive, resilient and efficient supply system is always there for community pharmacies, hospitals, and dispensing doctors. The Association is delighted that an HDA distributor is making use of its own intensive national network to enable this vital campaign.”
Matt Addison, Operations Director at Alliance Healthcare, stated:
“Each of the 16,500 pharmacies that we supply each day will play an important role in raising awareness of the Medicines to Ukraine campaign. Alliance Healthcare is fortunate to have an operation ready to help our pharmacy customers activate this important appeal and play its part to help those impacted by the war in Ukraine.”
Source: Alliance Healthcare. Alliance Healthcare UK Supports Medicines to Ukraine Campaign. [Date accessed 25/05/2023]
Related News
-
News Recipharm receives approval for the manufacture of a new microbiome-based therapeutic
Recipharm receives regulatory approval for the manufacture of a microbiome-based product for the prevention of Clostridioides difficile recurrent infection, under GenIbet Biopharmaceuticals and Seres Therapeutics. -
News AI search tool helps physicians to find the perfect clinical trials for their patients
A newly developed search tool uses AI to understand patient needs and reccomend the best clinical trials for their treatment, whilst keeping physicians centered in the process to ensure the best care. -
News Revamped EU drug regulations increase accessibility but limit innovation?
The European Union’s pharmaceutical industry could face a serious change in operations after Brussels published a proposal for the revamping of certain laws governing the industry. -
News Bormioli Pharma set out ambitious 50-in-5 sustainability targets
Bormioli Pharma has been designing innovative packaging solutions for the pharmaceutical industry for 200 years; in this interview Andrea Sentimenti described how they keep current in today's pharmaceutical landscape and how they are implementing s... -
News Digital-first experimental approach to optimise drug formulations
Merck and XtalPi Inc. collaborate on an AI-powered technology platform to predict the crystal morphologies of diabetic medication metformin HCl, validated by wet-lab experiments conducted with Merck’s expertise, in a ‘digital-first’ a... -
News To recruit or to retain - where is the pharma talent going?
Discover how the pharmaceutical workforce has evolved past the pandemic, and the challenges faced by the pharma industry during a talent acquisition and retention crisis. -
News NextPharma acquisition of chewable tablet manufacturing site from Takeda complete
NextPharma has completed their acquisition of a Norway-based manufacturing site, specialising in chewable tablet technologies for calcium/vitamin D3 from pharmaceutical giant Takeda. -
News Doctors Without Borders demands transparency from GSK on licensing agreements for preventative HIV treatment
GSK has signed licensed agreements with three companies to manufacture generic versions of its preventative HIV medicine for distribution in lower-income countries but calls for increased transparency is putting pressure on the drugmaker.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance